Article Information
History
- April 22, 2022.
Article Versions
- Version 1 (April 14, 2022 - 12:30).
- You are currently viewing Version 2 of this article (April 22, 2022 - 09:49).
- Version 3 (August 31, 2023 - 12:01).
- View Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Joanna C. Porter, (PhD FRCP)1,2,#,
- Jamie Inshaw, (PhD)3,
- Vincente Joel Solis2,
- Emma Denneny, (MRCP)1,2,
- Rebecca Evans, (MD)2,
- Mia I. Temkin4,*,
- Nathalia De Vasconcelos, (PhD)4,*,
- Iker Valle Aramburu, (PhD)4,*,
- Dennis Hoving, (PhD)4,*,
- Donna Basire1,
- Tracey Crissell2,
- Jesusa Guinto2,
- Alison Webb2,
- Hanif Esmail, (MRCP PhD)2,5,
- Victoria Johnston, (PhD FRCP)2,5,
- Anna Last, (PhD FRCP)2,6,
- Thomas Rampling, (MD PhD)2,5,
- Bryan Williams, (PhD, FRCP, FMedSci)2,5,
- Aiden Flynn, (PhD)3,
- Pauline T Lukey, (PhD)7,
- Veronique Birault, (PhD)8 and
- Venizelos Papayannopoulos, (PhD)4,#
- 1UCL Respiratory, University College London, UK
- 2University College London Hospitals NHS Trust, London, UK
- 3Exploristics, Belfast, N. Ireland
- 4Antimicrobial Defence lab, The Francis Crick Institute, London, UK
- 5National Institute for Health Research, University College London Hospital Biomedical Research Centre, UK
- 6Clinical Research Department, London School of Hygiene and Tropical Medicine, London, UK
- 7Target to Treatment Consulting Ltd, Stevenage, UK
- 8Translation, The Francis Crick Institute, London, UK
- ↵#Correspondence:
Professor Joanna C Porter, joanna.porter{at}ucl.ac.uk, Venizelos Papayannopoulos, veni.p{at}crick.ac.uk
↵* contributed equally